Filling the need for trusted information on national health issues
Coronavirus (COVID-19)
Americans are Leaving Home More Often Now Than in April, though Coronavirus Fears Remain
State Data and Policy Actions to Address Coronavirus
There have been over 3 million cases and 131,000 deaths due to COVID-19 in the U.S. Every state and Washington D.C. have eased or lifted at least one social distancing requirement — including 39 states that have eased or lifted stay-at-home orders.
COVID-19 Coronavirus Tracker
This tracker provides the number of cases and deaths from novel coronavirus by country, the trend in case and death counts by country, and a global map of showing which countries have cases and deaths. There have been over 11.8 million confirmed cases and 544,000 confirmed deaths worldwide.
Medicaid Emergency Authority Tracker: Approved State Actions to Address COVID-19
39 states are now addressing the coronavirus emergency with Medicaid/CHIP Disaster Relief State Plan Amendments (SPAs). This tracker also includes details on Section 1135 waivers and 1915 (c) Waiver Appendix K strategies and is regularly updated.
COVID-19 and Related State Data
Use this tool to create custom reports of COVID-19 and related state data. Group COVID-19 cases and deaths with indicators like total hospital beds, health insurance coverage and unemployment claims.
Health Disparities are a Symptom of Broader Social and Economic Inequities
Despite being long documented, racial and ethnic disparities in health have persisted and in some cases widened over time, with Black individuals and other groups of color faring worse compared to White individuals across many health status measures.Low-Income and Communities of Color at Higher Risk of Serious Illness if Infected with Coronavirus
This date note examines the share of non-elderly adults at higher risk of serious illness if infected with coronavirus by race/ethnicity and household income in 2018.
Communities of Color at Higher Risk for Health and Economic Challenges due to COVID-19
This brief analyzes data on underlying health conditions, health coverage and health care access, and social and economic factors by race and ethnicity to provide insight into how the health and financial impacts of COVID-19 may vary across racial/ethnic groups.
At-Home SARS-CoV-2 Testing: What Are the Options?
This interactive table includes vendors selling at-home SARS-CoV-2 diagnostic tests that have received emergency use authorization (EUA) from the Food and Drug Administration (FDA).
Five Things to Know about the Cost of COVID-19 Testing and Treatment
This brief answer key questions on affordability of COVID-19 testing and treatment for people who are uninsured and those insured through private coverage, Medicare, and Medicaid.
FAQs on Medicare Coverage and Costs Related to COVID-19 Testing and Treatment
These FAQs provide the latest guidance on testing and treatment related to COVID-19 for Medicare beneficiaries.
Key Questions About the New Medicaid Eligibility Pathway for Uninsured Coronavirus Testing
This issue brief answers key questions about how the new eligibility pathway is being implemented, drawing on frequently asked questions issued by the Centers for Medicare and Medicaid Services.